Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma - Concepedia

Concepedia

Publication | Open Access

Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma

DOI Full Paper Access

54

Citations

26

References

2018

Year

Wesley E. Barry, Jeremy R. Jackson, Grace E. Asuelime, Hongwei Wu, Jianping Sun, Zesheng Wan, Jemily Malvar, Michael A. Sheard, Larry Wang, Robert C. Seeger,

Clinical Cancer Research

Abstract

The combination of dinutuximab and adoptively transferred human aNK cells following surgical resection of primary neuroblastomas significantly improves survival of immunodeficient mice.

References

	Year	Citations

Page 1